Cargando…
EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study
PURPOSE: To describe screening failures in the EVEREST study by examining the imaging characteristics that enabled differentiation of polypoidal choroidal vasculopathy (PCV) from cases that were subsequently diagnosed not to be PCV. METHODS: Post-hoc analysis of 34 patients with PCV reported as scre...
Autores principales: | Tan, Colin S., Ngo, Wei Kiong, Lim, Louis W., Tan, Nikolle W., Lim, Tock H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045476/ https://www.ncbi.nlm.nih.gov/pubmed/27142805 http://dx.doi.org/10.1007/s00417-016-3333-y |
Ejemplares similares
-
EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy
por: Tan, Colin S., et al.
Publicado: (2019) -
EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy
por: Tan, Colin S, et al.
Publicado: (2015) -
Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial
por: Lim, Tock H., et al.
Publicado: (2020) -
Investigation of precursor lesions of polypoidal choroidal vasculopathy using contralateral eye findings
por: Kang, Se Woong, et al.
Publicado: (2016) -
The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers
por: Luo, Mingyue, et al.
Publicado: (2020)